FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Ilhan Omar hit with expulsion threat as GOP lawmaker vows to boot her from Congress over DOJ probe

The United States of Fraud: California Scheme Used Homeless, Elderly People to Steal Billions

Breaking: Israel Orders Full West Bank Lockdown After IDF Troops Stop Terror Attack

EXCLUSIVE: Fed timeline challenges reports of migrant baby facing immigration judge alone

House Democrats make push for western Michigan seat that’s long been a GOP stronghold

Maryland ballot measure aims to eliminate the state’s last GOP-held House district

Trump sidelines sweeping Russia sanctions as GOP allies warn pressure on Putin is slipping

Trump pushback, Biden ‘disaster’ and gender surprise: 5 key moments from Kansas Senate debate

Michigan Senate race draws presidential-level star power in final stretch

Antifa supporter charged with stealing GOP campaign signs in NY race to replace Stefanik

Supreme Court blocks use of student IDs as voter identification in New Hampshire

Blanche won’t rule out DOJ blocking election certification in ‘doomsday’ scenario

Utah man charged with attempted hate crime after alleged threat to ‘blow up’ synagogue

Trump invokes Defense Production Act to boost US fuel refining capacity at Iowa rally

‘I basically snapped’: New Jersey mayor charges at resident during chaotic council meeting

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”